WallStreetZenWallStreetZen

NASDAQ: ELAB
Elevai Labs Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ELAB past revenue growth

How has ELAB's revenue growth performed historically?
Company
123.5%
Industry
145.63%
Market
17.92%
ELAB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ELAB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ELAB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ELAB earnings and revenue history

Current Revenue
$1.7M
Current Earnings
-$4.3M
Current Profit Margin
-251.2%

ELAB Return on Equity

Current Company
-173.5%
Current Industry
-63.5%
Current Market
188.7%
ELAB's Return on Equity (-173.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ELAB announces earnings.

ELAB Return on Assets

Current Company
-121.5%
Current Industry
2.9%
ELAB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ELAB Return on Capital Employed

Current Company
-110%
Current Industry
19.5%

ELAB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ELAB$1.71M-$4.27M-$4.30M+4,450.66%N/A
ABVC$152.43k-$7.74M-$10.52M-31.73%N/A
IMNN$0.00-$19.88M-$19.51M-100.00%N/A
ATHE$0.00N/A-$8.03MN/AN/A
MIRA$0.00-$8.53M-$11.98MN/AN/A
View Top Biotech Stocks

Elevai Labs Earnings & Revenue FAQ

What were ELAB's earnings last quarter?

Elevai Labs (NASDAQ: ELAB) reported Q4 2023 earnings per share (EPS) of -$0.08, up 18.84% year over year. Total Elevai Labs earnings for the quarter were -$1.16 million. In the same quarter last year, Elevai Labs's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Elevai Labs stock.

What was ELAB's earnings growth in the past year?

As of Q2 2024, Elevai Labs's earnings has grown year over year. Elevai Labs's earnings in the past year totalled -$4.30 million.

What was ELAB's revenue last quarter?

Elevai Labs (NASDAQ: ELAB) reported Q4 2023 revenue of $698.59 thousand up 402.95% year over year. In the same quarter last year, Elevai Labs's revenue was $138.90 thousand.

What was ELAB's revenue growth in the past year?

As of Q2 2024, Elevai Labs's revenue has grown 123.5% year over year. This is 22.14 percentage points lower than the US Biotechnology industry revenue growth rate of 145.63%. Elevai Labs's revenue in the past year totalled $1.71 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.